Article metrics

Download PDFPDF

748 A phase 1/2, open-label, dose-escalation, safety and tolerability study of NC762 in subjects with advanced or metastatic solid tumors
Free

 

Online download statistics by month:

Online download statistics by month: November 2022 to August 2024

AbstractFullPdf
Nov 2022164011
Dec 20222603
Jan 20234403
Feb 20237207
Mar 20237409
Apr 20235002
May 20236602
Jun 20237407
Jul 202336013
Aug 20236009
Sep 20236804
Oct 202336807
Nov 20238807
Dec 202313008
Jan 20245207
Feb 20247405
Mar 2024102010
Apr 20244401
May 20246008
Jun 20244204
Jul 20246609
Aug 20244606
Total18060142